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AbstrAct
Objectives of this study were to investigate whether AQP1 and AQP5 expression is 
altered during intervertebral disc degeneration and if hypoxia and HIF-1 regulate their 
expression in NP cells. AQP expression was measured in human tissues from different 
degenerative grades; regulation by hypoxia and HIF-1 was studied using promoter 
analysis and gain- and loss-of-function experiments. We show that both AQPs are 
expressed in the disc and that mRNA and protein levels decline with human disease 
severity. Bioinformatic analyses of AQP promoters showed multiple evolutionarily 
conserved HREs. Surprisingly, hypoxia failed to induce promoter activity or expression 
of either AQP. While genomic chromatin immunoprecipitation showed limited binding 
of HIF-1α to conserved HREs, their mutation did not suppress promoter activities. 
Stable HIF-1α suppression signiicantly decreased mRNA and protein levels of both 
AQPs, but HIF-1α failed to induce AQP levels following accumulation. Together, 
our results demonstrate that AQP1 and AQP5 expression is sensitive to human disc 
degeneration and that HIF-1α uniquely maintains basal expression of both AQPs in NP 
cells, independent of oxemic tension and HIF-1 binding to promoter HREs. Diminished 
HIF-1 activity during degeneration may suppress AQP levels in NP cells, compromising 
their ability to respond to extracellular osmolarity changes. 
IntroductIon
The intervertebral disc is a specialized organ that 
allows for normal biomechanical function of the spine. 
Each disc contains an outer ibrocartilagenous annulus 
ibrosus (AF), surrounding a gelatinous nucleus pulposus 
(NP). Two features uniquely characterizing the NP are 
hypoxia [1, 2] and elevated osmolarity yielding high 
tissue water content. Previous reports have demonstrated 
a constitutive expression of HIF-1α and HIF-2α in the 
NP [3–5], which control glycolytic metabolism, matrix 
production, and cell survival under hypoxic conditions 
[6-8]. High concentration of proteoglycans whose 
glycosaminoglycan side-chains are hydrophilic promotes 
water retention by the NP, allowing the disc to resist 
compressive loads and permit spinal motion [9–12]. NP 
cells experience daily luctuations in water content, with 
measurements showing 8% water loss upon loading, 
highlighting the importance of controlling water transport 
to withstand osmotic and volumetric changes in these 
cells [12]. With aging, the intervertebral discs are highly 
susceptible to degeneration, characterized by loss of 
swelling pressure and hydration of the NP and pain [13, 
14]. Therefore, tight regulation of water transport in NP 
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cells is of utmost importance for disc function. 
The Aquaporins (AQPs) are a thirteen-member 
family of water channels, driven by osmotic gradient 
[15]. Aquaporin 1 (AQP1), the irst family member to be 
described, is found in many secretory and osmotically 
active tissues [16]. Expression of AQPs 1-3 has been 
shown in the intervertebral disc [17, 18]. While AQP2 
expression is responsive to osmotic changes in NP cells 
[18], AQP1 showed only a small increase at 5% O2 [19]. In other tissues, expression of many members of the 
Aquaporin family including AQPs 1 and 5 have been 
linked to oxygen tension and ΗΙF-1α expression [20–
28]. Additional studies have identiied HIF-1α as a key 
regulator of AQP 1 and 5 induction in retinal vascular 
endothelial, Schwann and lung epithelial cells [29–31]. 
Interestingly, Kaweida et al. [32] reported a suppressive 
effect of HIF-1α on AQP5 expression in lungs of mice 
exposed to hypoxia and in lung epithelial MLE-12 cells, 
indicating that hypoxic regulation of AQPs may be cell-
type speciic. 
The goal of this study was to investigate whether 
AQP expression is sensitive to intervertebral disc 
degeneration and if physiological hypoxia and HIF-1α 
play a role in their regulation in NP cells. We show that 
both AQPs have prominent membrane localization in disc 
tissues. Importantly, unique to NP cells, while expression 
is not hypoxia sensitive, it requires HIF-1 for maintaining 
basal levels. Noteworthy, under hypoxia, the ability of 
HIF-1α to bind conserved HREs in AQP promoters is not 
required for driving expression. 
results
Aquaporin 1 and 5 expression levels 
correlate with degenerative Grade in Human 
Intervertebral discs
AQP1 and AQP5 mRNA levels decreased in 
degenerative NP compared to non-degenerative human 
NP tissues, difference reached signiicance in high 
grades of degeneration (graded ≥7) (AQP1: p=0.0018; 
AQP5: p=0.0472) (Fig.1A and 1B). Interestingly, both 
mRNA levels and percentage of cells immunopostive for 
AQPs 1 and 5 in NP were correlated, demonstrating that 
discs with high levels of AQP1 also have high levels of 
AQP5 (mRNA: p < 0.0001; protein: p=0.04) (Fig.1C and 
1D). Moreover, AQP1 and AQP5 were localized to cell 
membranes of NP cells (Fig. 1E) in the majority of cells 
within non-degenerative discs (graded ≤4). Noteworthy, 
the percentage of immunopositive cells for both AQPs 1 
and 5 decreased in degenerative discs, this was signiicant 
in mid-grade degenerative discs (graded 4-7) compared 
to non-degenerative discs for AQP1 (p=0.0484) (Fig. 1F) 
and in both mid-grade and high-grade degenerative discs 
compared to non-degenerative discs for AQP5 (p = 0.003 
and p = 0.0397 respectively) (Fig.1G). 
Aquaporins 1 and 5 are expressed in the normal 
Intervertebral disc
Since AQP expression was observed to be sensitive 
to disc degeneration, it was of interest to study their 
expression and regulation in native NP tissue. For this 
purpose, sections of NP and AF from rat intervertebral 
discs were irst stained with antibody to detect either 
AQP1 (Fig. 2C and 2D) or AQP5 (Fig. 2E and 2F) 
localization. Additional sections were counterstained 
with H&E for assessment of general tissue morphology 
(Fig. 2A and 2B). Both AQP1 and AQP5 protein were 
detected in NP and AF tissues, with AQP1 showing 
more robust plasma membrane expression than AQP5 
in NP sections. Protein expression of AQPs was further 
assessed in rat NP tissue and cultured NP and AF cells 
with Western blot analysis and immunoluorescence 
microscopy, respectively. As shown in Fig.2G, both AQPs 
are expressed in freshly isolated NP tissue from three rats 
as evidenced by speciic bands present at 29 kDa. Cultured 
NP and AF cells (Fig. 2H-2K) also expressed both AQPs. 
AQP mRNA expression was measured for both AQPs in 
NP (Fig. 2L) and AF (Fig. 2M) tissue isolated from three 
rats. All experimental data demonstrate a trend of similar 
expression of both AQPs 1 and 5 in NP cells and tissue. 
the Proximal Promoter regions of AQP1 and 
AQP5 contain conserved Hypoxia response 
elements
To deine the regulatory mechanism controlling AQP 
expression in NP cells in hypoxia, the promoter regions of 
AQP1 and AQP5 were analyzed. First, the ECR Browser 
(http://ecrbrowser.dcode.org/) was used to evaluate the 
level of interspecies sequence conservation across the 
entire AQP1 gene (Fig. 3A), revealing high conservation 
of exonic sequences (blue). Next, 1.5 kb of the human 
AQP1 promoter was scanned for the presence of hypoxia 
responsive elements (HREs) using the JASPAR core 
database (http://jaspar.genereg.net/). Two putative HREs: 
HRE 1 at -1338/-1334 bp and HRE 2 at -1455/-1448 bp 
of the human promoter, were identiied (Fig. 3B). Multiz 
alignment was also performed for both HREs. As shown 
in Fig. 3B, HRE 1 demonstrates high level of sequence 
conservation between multiples vertebrates. Similarly, 
evaluation of AQP5 gene sequence homology using the 
ECR Browser also showed high conservation of exonic 
regions (blue) and UTRs (yellow) (Fig. 4A). Two HREs 
sites were returned by the JASPAR database, in the rat 
AQP5 promoter they are located at HRE 1 at -419/-414 
bp and HRE 2 at -330/-326 bp (Fig. 4B). Again, Multiz 
alignment of HREs of AQP5 promoter showed high 
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sequence conservation between shown species (Fig. 4B).
Promoter Activities of AQP1 and AQP5 are not 
Hypoxia-Inducible in nP cells
To determine regulation of promoter activity by 
hypoxia, rat NP cells were transfected with reporters 
containing either AQP1 or AQP5 promoters and luciferase 
activity was measured under normoxia and hypoxia (1% 
O2). Hypoxic culture failed to induce activity of either the wild-type AQP1 (Fig. 3D) or the wild-type AQP5 (Fig. 
4D) promoters. 
transcription AQP1 and AQP5 is Independent of 
HIF-1α Binding to HREs in Promoters
The hypothesis that HIF-1 regulates AQP 
transcription via HRE sites was speciically tested irst by 
measuring activity of constructs harboring mutations of the 
highly conserved HRE sites (HRE1 in AQP1 and HREs 1 
and 2 in the AQP5 promoter) in rat NP cells. As shown 
in Fig. 3D, mutation of HRE 1 in the AQP1 promoter did 
not alter its activity in response to hypoxia. Similarly, 
mutation of HRE 2 in the AQP5 promoter did not affect 
response to hypoxia. Mutation of HRE 1 in the AQP5 
Figure 1: AQP expression decreases with degeneration in human intervertebral disc samples. A and B, Levels of AQP1 (A) 
and AQP5 (b) mRNA decrease with disc degeneration (AQP 1:p=0.0018; AQP 5: p=0.0472). C and D, Linear correlation between mRNA 
(c) and protein (d) levels of AQPs 1 and 5 in disc samples, irrespective of histological grade (mRNA: p<0.0001; protein p=0.004). (e), 
Localization of AQP1 and AQP5 to cellular and nuclear membranes in NP cells. F and G, Percentage of cells immunopositive for AQP1 
(F) or AQP5 (G) is decreased in degenerative discs. Signiicance in mid-grade degenerate discs (graded 4-7) compared to non-degenerative 
discs for AQP 1 (p=0.0484) and in both mid-grade and high-grade degenerative discs compared to non-degenerative discs for AQP5 (p = 
0.003 and p=0.0397, respectively). In A, B, and C mRNA levels are multiplied by factor of 105. Scale bar in E is 25 µm.
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Figure 2: AQPs 1 and 5 are expressed in healthy rat disc. Sections of rat intervertebral disc were stained with either H&E (A, b) 
or antibodies against AQP1 (H, I) or AQP5 (e, F). Note both AQPs are expressed in NP and AF tissues (arrows). In NP cells, prominent 
plasma membrane localization was seen. G, Western blot of AQPs from three rats demonstrates expression of 29 kDa AQP1 and AQP5 
protein in NP tissues. Immunoluorescent detection of AQP1 and AQP5 protein in cultured NP and AF cells (H-K). L and M, Comparable 
levels of AQP 1 and 5 mRNA expression in rat NP (l) and AF (M) tissue samples was seen. Scale bar in H-K is 100 µm.
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Figure 3: Functionality of conserved Hres in the promoter regions of the AQP1 gene. A, Analysis using the Evolutionary 
Conserved Regions Browser (http://ecrbrowser.dcode.org/) demonstrates sequence conservation between vertebrates in the 2 kb AQP1 
promoter. ECR threshold is set at 80%. AQP1 promoter: red, 5’ UTR; yellow, exons; blue, introns; peach, transposons; and simple repeats, 
green. b, Multiz alignment of two HREs in the AQP1 promoter to evaluate inter-species sequence homology. c, Schematic representation 
of wild-type (WT) and HRE-mutant (HREmt) AQP1 promoter constructs. d, Promoter activity remains constant between normoxia (NX, 
21% O2) and hypoxia (HX, 1% O2) in rat NP cells. ChIP results for HIF-1α binding to HREs in human NP cells untreated (CTR), treated with 2mM DMOG, or cultured under hypoxia for 24 h (HX). qRT-PCR was performed on ChIP samples using speciic primers for AQP1 
HRE 1 (e), AQP1 HRE 2 (F), and VEGF-A HRE (G). Data is represented as fold enrichment in HIF-1α binding over negative control 
primers, positive binding is deined as enrichment ≥ 5 fold.
Oncotarget11950www.impactjournals.com/oncotarget
promoter, either alone or in concert with HRE 2 mutation, 
resulted in an increase in promoter activity under hypoxia. 
To investigate whether these conserved HREs bind HIF-1α 
and whether binding was dependent upon oxygen tension, 
genomic chromatin immunoprecipitation for HIF-1α was 
performed in human NP cells cultured in normoxia with 
or without DMOG, a prolyl hydroxylase inhibitor or under 
hypoxia. Primers were designed to speciically amplify 
only the region containing a single AQP HRE, previously 
characterized VEGF-A HRE was used as positive control 
Figure 4: Functionality of conserved Hres in the promoter regions of the AQP5 gene. A, Analysis using the Evolutionary 
Conserved Regions Browser demonstrates sequence conservation between multiple species in the 1 kb AQP5 promoter. b, Multiz alignment 
of two HREs in the AQP5 promoter to evaluate inter-species sequence homology. c, Schematic representation of wild-type (AQP5-WT) 
and HRE-mutant (AQP5-M1, -M2, M1+2) promoter constructs. d, Similar promoter activity was observed in rat NP cells cultured under 
normoxia (NX, 21% O2) or hypoxia (HX, 1% O2). ChIP results for HIF-1α binding to HREs in human NP cells untreated (CTR), treated with 2 mM DMOG, or cultured under hypoxia for 24 h (HX). qRT-PCR was performed on samples using speciic primers for AQP5 HRE 
1 (e) and AQP5 HRE 2 (F). Data is represented as fold enrichment in HIF-1α binding over negative control primers positive binding is 
deined as enrichment ≥ 5 fold.
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[36]. HIF-1α bound to a limited extent only to HRE 1 and 
HRE 2 of AQP1 promoter under hypoxic conditions, no 
enrichment in binding over negative control primers was 
seen under normoxia with or without DMOG treatment 
(Fig. 3E and 3F). On the other hand, enrichment in HIF-
1α binding to both HREs in AQP5 promoter with DMOG 
treatment and to HRE 2 under hypoxia was seen (Fig.4E 
and 4F). Despite the fact that HIF-1α could interact 
with all four HREs to varying degree under at least one 
experimental condition, levels of binding were several-
fold lower than that of HIF-1α with the known VEGF-A 
HRE (Fig. 3G). 
Hypoxia Fails to Induce expression of AQP 1 and 
AQP5 in nP cells
To test the effect of hypoxia on expression levels of 
AQP1 and AQP5, rat NP cells were cultured in 1% O2 for 8 to 72 h and mRNA and protein levels were measured. 
As shown in Fig. 5A and 5B, hypoxic culture did not 
signiicantly affect mRNA expression of either AQP in 
NP cells. Western blots and corresponding densitometric 
analyses conirm that hypoxia does not affect protein 
expression of either AQP1 (Fig.5C and 5E) or AQP5 (Fig. 
5D and 5F). To investigate possible changes in protein 
localization in response to hypoxia, cells were incubated in 
hypoxia for 24 h before immunoluorescent staining with 
antibodies directed against either AQP1 or AQP5 along 
with N-Cadherin. Fig. 5G-5H shows that expression and 
localization of both AQPs remain unaffected by hypoxia.
HIF-1α is Necessary for Basal Expression of 
Aquaporins 1 and 5 in nP cells
The effect of HIF-1 on AQP expression in rat NP 
cells was further investigated using gain- and loss-of-
function studies. To block prolyl hydroxylase activity 
and accumulate HIF-1α protein, cells were treated 
with 1 mM DMOG. Western blot and corresponding 
densitometric analysis (Fig. 6A and 6B) show that, 
while DMOG treatment led to accumulation of HIF-1α 
protein, expression levels of AQP1 and AQP5 remained 
unchanged. Next, rat NP cells were co-transfected with 
the wild-type reporter constructs of either the AQP1 or the 
AQP5 promoter along with siHIF-1α or a control siRNA. 
Results clearly showed that suppression of HIF-1 by 
siHIF-1α did not affect promoter activity of either wild-
type AQP promoter construct (Fig. 6C). To assess effect of 
stable HIF-1 suppression on AQP expression, human NP 
cells were transduced by lentivirus co-expressing shHIF-
1α and YFP. As shown in Fig. 6D, YFP signal indicated 
that lentiviral delivery resulted in high infection rates and 
a robust transgene expression in NP cells. As expected, 
shHIF-1α signiicantly decreased mRNA expression of 
HIF-1α compared to sh-control (Fig. 6E-6G). Importantly, 
silencing of HIF-1α resulted in dramatic decrease in 
mRNA expression of both AQP1 and AQP5 in human NP 
cells (Fig. 6E). Moreover, HIF-1α knockdown resulted in 
signiicant reduction in protein levels of both AQP1 and 
AQP5 (Fig. 6G). 
dIscussIon
This study demonstrates the importance of 
maintenance of AQP levels for human disc health and 
deines the unique HIF-1α-dependent regulation of AQPs 
1 and 5 in NP cells. We show for the irst time that AQP5 
is expressed in the disc and that expression levels of both 
of these AQPs are correlated with severity of human disc 
disease. Unlike reports in other cell types, we show that 
expression of these AQPs is not hypoxia-inducible in NP 
cells. Importantly, our results show that, while HIF-1α 
positively regulates basal expression of both AQPs, it does 
so independently of conserved HREs identiied in their 
promoters. Restoration of AQP levels and osmoregulatory 
capacity of cells by modulating HIF-1 signaling may 
represent a novel therapeutic strategy to mitigate effects 
of disc disease. 
Biomechanical function of the intervertebral disc 
is intricately linked to NP osmotic properties and the 
ability of matrix to bind water. Since AQPs are crucial in 
maintaining cellular water homeostasis under dynamic 
osmotic conditions and have been shown to co-transport 
many important metabolites such as CO2 and O2 [37, 38], it was important to investigate if their expression is 
sensitive to disc degeneration. Our results clearly show 
that levels of both AQPs are lower in NP tissues with 
progressive degeneration. These results provide further 
support to observations by Wang et al. [19], who showed 
differential expression of AQP1 in young versus aged 
rabbit discs, suggesting a possible role in age-related 
degeneration of the disc. Importantly, AQP 1 and 5 
expression levels are sensitive to changes in extracellular 
osmolarity [31, 39, 40]. Likewise, AQP2 expression 
in NP cells is osmo-dependent [18]. Thus, decreased 
levels of these and other AQPs possibly indicate loss of 
osmoregulatory capacity of NP cells and may result in 
compromised cell function. Relevant to this discussion, 
clinical studies of low back pain patients have shown a 
strong inverse relationship between pain and T1ρ MRI 
and opening pressure, measures of disc hydration and 
osmotic pressure, respectively [41]. These changes in 
tissue osmotic properties are largely attributed to loss 
of aggrecan and other GAGs as catabolic activities 
overwhelm normal anabolism of the matrix [42, 43]. It 
is thus possible that decreased AQPs may be a relection 
of changing osmotic status of the tissue. Nevertheless, 
our results point to AQP loss as another critical step that 
characterizes this pathogenic process. 
Interestingly, our results show a strong correlation 
between expression of AQP1 and AQP5 in NP, 
Oncotarget11952www.impactjournals.com/oncotarget
Figure 5: expression of AQPs 1 and 5 is refractory to hypoxia in nP cells. A and B, AQP1 (A) and AQP5 (b) mRNA levels 
in rat NP cells cultured in normoxia (NX, 21% O2) or hypoxia (HX, 1% O2) for 8-72 h. mRNA expression showed no signiicant change under hypoxia. C-F, Western blot and corresponding Densitometric analysis shows that protein expression of AQP1 (c, e) and AQP5 (d, 
F) in rat NP cells is refractory to hypoxic conditions. G and H, Immunoluorescent detection of AQP1 and AQP5 in NP cells following 
24 h in normoxia (NX) or hypoxia (HX). N-Cadherin is used as a marker for plasma membrane staining. Scale bar in G and H is 100 µm.
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independent of degenerative grade, suggesting a common 
regulatory mechanism. It was therefore of high interest to 
investigate how expression of AQPs 1 and 5 is regulated in 
healthy tissues. Our results show robust expression of not 
only AQP1 but also AQP5 in discal tissues and cultured 
cells. This inding was in line with previous reports 
showing presence of AQPs 1-3 in the disc [17, 18], while 
AQPs 1 and 5 are expressed in cartilage, a tissue that also 
experiences low-oxygen, high-osmolarity environment 
similar to that of the NP [44–46]. Expression of multiple 
AQPs in NP is not surprising, as water balance in this 
osmotically challenging tissue must be tightly controlled 
for cell survival and functional activities. 
Physiological hypoxia, a distinguishing feature of 
the NP environment, is a critical regulator of cell survival 
and function of these cells [3, 6–8, 47]. We therefore 
asked the question of whether hypoxia controls the 
expression of AQPs 1 and 5 in NP cells. Previous studies 
Figure 6: HIF-1α maintains basal AQP expression in NP cells. A and B, Western blot (A) and corresponding densitometric 
analysis (b) show that treatment of rat NP cells with DMOG (1mM) has no effect on levels of AQP1 and AQP5, as expected accumulation of 
HIF-1α protein by DMOG is evident. c, Suppression of HIF-1α expression by co-transfection with Si-HIF-1α does not signiicantly change 
activities of AQP1 and AQP5 promoters in comparison to rat NP cell transfected with control siRNA. d, YFP expression demonstrates 
eficient transduction of human NP cells infected with lentivirus encoding both HIF-1α shRNA and YFP. e, Stable Silencing of HIF-1α 
by lentiviral Sh-HIF-1α causes strong decrease in basal levels of both AQP 1 and AQP5 mRNA in human NP cells. As expected, HIF-1α 
mRNA levels were signiicantly lower in silenced cells compared to cells that received control shRNA. F and G, Western blot (F) and 
corresponding densitometric analysis (G) shows that HIF-1α silencing in human NP cells results in robust decrease in both AQP 1 and 
AQP5 protein levels. 
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have shown that expression of AQP1 and 5 is sensitive to 
hypoxia and that activity of their proximal promoters is 
controlled by HIF-1α [29, 31]. In contrast to these reports, 
our results show that promoter activity is insensitive to 
hypoxia. Moreover, while promoters contain multiple 
HREs, mutation of highly conserved HRE 1 (-1338/-1334 
bp) of AQP1 and HRE 2 (-330/-326 bp) of AQP5 had no 
impact on their activities suggesting that these motifs are 
not required for regulation. Our lab has recently reported 
unique regulation of CCN2, HSP70, and GlcAT-1 [6, 
47, 48] by HIF-1α in NP cells. In the case of CCN2, 
deletion and mutation analyses of HREs indicated indirect 
regulation by HIF-1α [47], similar to what we have 
presented here for AQP1 and AQP5. These data support 
the notion that, in the unique NP environment, HIF acts 
as a regulator either in a complex that does not require 
HIF-DNA binding or at a level other than transcription. 
In stark contrast to NP cells, HRE 1 of AQP1 has been 
shown to modulate HIF-1α response in human retinal 
vascular endothelial cells (HRVECs) [29], while HREs 
in AQP5 promoter control HIF-1α dependent activation 
in mouse lung epithelial cell line MLE-15 [31]. These 
results raised an important question: Can AQP-HREs 
even interact and bind to HIF-1α in NP cells? Results 
of genomic ChIP analysis clearly showed that, while a 
low level binding could be detected either in presence of 
DMOG or under hypoxia, it is much lower than binding 
to the validated HRE in promoter of VEGF-A, an hypoxia 
and HIF-inducible gene in NP cells [5, 36]. Interestingly, 
a distinct pattern of HIF-1-HRE interaction was observed 
for individual AQPs implying that for AQP1 hypoxia-
speciic co-factors seemed necessary for HRE binding 
as no enrichment was observed with DMOG, while high 
levels of HIF-1α from DMOG are suficient to force 
binding to the AQP5 HREs. Supporting our mutagenesis 
and ChIP analysis, transfection results using SiHIF-1α 
with AQP reporters indicated that depletion of HIF-1α 
from the system had no effect on promoter activities.
While results of promoter experiments suggested 
that hypoxia and HIF-1 do not contribute to controlling 
activities of reporters, it was likely that the regulatory 
motif(s) could lie outside of these promoter fragments or 
the regulation was at post-transcriptional or translational 
level. To investigate this possibility hypoxic expression of 
AQPs was assessed. Again, highlighting unique response 
of NP cells, we observed lack of hypoxic induction of 
either AQPs at the mRNA or protein level. Since in NP 
cells HIF-1α levels are refractory to oxygen-mediated 
degradation, there is no appreciable increase in HIF-1α 
level in hypoxia. Thus, to investigate whether elevation 
in HIF-1α levels can induce AQP expression, we treated 
cells with DMOG to force accumulation. Notably, despite 
dramatic increase in HIF-1α protein levels, AQP levels 
remained unaltered. This is in agreement with our results 
that showed lack of AQP inducibility by increased HIF-1 
activity under hypoxia. Finally, we determined whether 
HIF-1α was necessary for maintenance of basal expression 
of AQPs in NP cells. Results of stable suppression of HIF-
1α showed approximately 80% and 60% decrease in both 
AQPs’ mRNA and protein levels, respectively. These 
results clearly suggest that AQP1 and 5 are HIF-1 target 
genes. It is also possible that the expression of AQPs is 
indirectly controlled through other HIF-1 targets. That 
hypoxia or DMOG does not induce AQP expression in NP 
cells may be partially attributed to the fact that suficient 
HIF-1α activity is always present to maintain optimal 
levels of AQPs in NP cells. 
There is indirect evidence to suggest that changes 
in local oxygen tension resulting from annular issures 
during degeneration may compromise HIF-1α activity 
in the NP possibly due to dysregulation of protein 
turnover and co-factor expression [4, 7, 49, 50]. Notably, 
expression of PHD3 that serves as important HIF-1 co-
factor decreases with degeneration, implying diminished 
HIF-1α activity [35]. Based on these previous reports and 
our current indings, it is plausible that changes in HIF-1α 
expression and/or activity with degeneration may result in 
decreased AQP expression, causing further exacerbation 
of disease. The potential role of AQPs in the exacerbation 
of intervertebral disc degeneration suggests therapies 
targeted at restoring AQP expression and function within 
degenerative discs may provide a new strategy for 
reestablishing the osmotic balance within the IVD.
MAterIAls And MetHods 
Human tissue collection and grading for 
investigation of AQP expression
Human lumbar IVD tissues were obtained at 
surgery or post-mortem (PM) examination with informed 
consent of the patient or relatives (Shefield Research 
Ethics Committee #09/H1308/70). Seven PM IVDs were 
recovered from two donors, comprising intact IVDs 
within the complete motion segment from which the 
IVDs were removed. 73 surgical IVD tissue samples were 
obtained from 73 patients undergoing micro-discectomy 
procedures for treatment of low back/neck pain and root 
pain as caused by prolapse of the IVD (Supplemental 
Table 1 for sample details). NP tissue was very carefully 
separated from the AF and endplate fragments under 
stereomicroscope [33] and was divided into two - half was 
ixed in 10% neutral buffered formalin and processed for 
histological and immunohistochemical examination. The 
remaining NP tissue was used for RNA isolation. H&E 
stained sections, used to score degree of morphological 
degeneration, were scored numerically 0-3 for four 
features as reported previously [33]. Gene expression 
samples were classiied as non-degenerative (≤ 3.9), mid-
grade degenerative (4-6.9) and high grade degenerative 
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(≥7) based on histological examination. AF tissues were 
not included in any of the analyses due to chances of 
cross contamination from extraneous connective tissues, 
endplate fragments and blood. Grading was performed 
independently by two researchers and grades were 
averaged. 
Isolation of nP and AF cells and treatments of 
cells
Rat NP and AF and human NP (2 samples, 33 yrs. 
(F) Autopsy, grade 1 and 39 yrs. (M), Surgical waste, grade 
2) cells were isolated using a method previously described 
by Risbud et al. [4] Collection of animal and human 
tissues for cell isolation was performed as per approved 
protocols by Jefferson’s IACUC and IRB respectively. 
Cells were passaged and maintained in monolayer in 
Dulbecco’s Modiied Eagles Medium (DMEM) together 
with 10% fetal bovine serum (FBS) supplemented with 
antibiotics. For hypoxic culture NP cells were maintained 
in a Hypoxia Work Station (Invivo2 300, Ruskin, UK) 
with a mixture of 1% O2, 5% CO2, and 94% N2 for 8 to 72 h. In some experiments, cells were treated with 1-2mM 
dimethyl oxalylglycine (DMOG).
Immunohistochemical analysis
Human discs: Immunohistochemistry conirmed 
and localized production of AQPs 1 and 5 in 29 IVDs; 
7 PM and 22 surgical samples (Supplementary Table 1). 
Tissue sections were dewaxed, rehydrated, endogenous 
peroxidases quenched. Samples were blocked in rabbit 
(AQP1) or goat (AQP5) serum, then incubated overnight 
at 4°C with mouse anti-human AQP1 (1:10), or rabbit 
anti-human AQP5 (1:10), with pre-immune mouse and 
rabbit IgG (Abcam) used as negative control at equal 
IgG concentrations. After washing, AQP1 sections were 
incubated with biotinylated rabbit anti-mouse antiserum 
(1:400; Abcam) and AQP5 sections incubated with 
biotinylated goat anti-rabbit antiserum (1:500; Abcam) 
and binding detected by formation of streptavadin-
biotin complex (Vector Laboratories, Peterborough, UK) 
with 3,3’-diaminobenzidine tetrahydrochloride solution 
(Sigma-Aldrich). Sections were counterstained with 
Mayers Haematoxylin (Leica Microsystems), dehydrated, 
cleared and mounted in Pertex (Leica). Sections were 
visualized and images captured using an Olympus 
BX60 microscope and QCapture Pro v8.0 software 
(MediaCybernetics, Marlow, UK). Random ields of view 
were assessed for immunopositive cells until a total of 200 
NP cells were counted, the number of immunopositive 
cells was expressed as a percentage of the total count. 
Rat discs: Transverse and coronal sections (6-8 μm) 
of rat spines were deparafinized in xylene, rehydrated 
through graded ethanol and stained with Alcian Blue, 
eosin and hematoxylin. Sections were blocked with goat 
serum (Invitrogen) and incubated with the AQP1 (1:100; 
Millipore) or AQP5 (1:100; Calbiochem) antibodies 
in 2% bovine serum albumin at 4 °C overnight. After 
washing, the bound primary antibody was incubated with 
Alexa luor-488 conjugated secondary antibody (1:50; 
Invitrogen) and imaged using a luorescence microscope 
(Nikon, Japan).
Plasmids and reagents
Human AQP1 (AQP1-WT, AQP1-HREmt) and 
AQP5 (AQP5-WT, AQP5-M1, AQP5-M2, AQP5-M1+2) 
constructs were gift from Drs. K. Sakurai, Chiba 
University, Japan [29] and Z. Borok, University of 
Southern California [31] respectively. SiHIF-1α plasmid 
(#21103), from Dr. C. Cepko was from Addgene. For 
internal transfection control, vector pRL-TK (Promega) 
containing Renilla reniformis luciferase gene was used. 
real-time rt-Pcr
Total DNA-free RNA was extracted from NP cells 
using RNAeasy mini columns (Qiagen), and cDNA made 
using EcoDry premix (Clontech). cDNA and gene-speciic 
primers (IDT, IA) were added to SYBR Green master 
mixture and mRNA expression quantiied using Step-One 
Plus Real-time PCR System (Applied Biosystems). Hprt1 
was used to normalize gene expression. For human NP 
tissues, extracted tissue RNA was DNase treated (Qiagen) 
and puriied using Qiagen MinElute Cleanup kit before 
cDNA synthesis using MMLV Reverse Transcriptase 
(Bioline, London, UK) and random hexamers. Real-time 
PCR analysis was performed using pre-designed, FAM-
labeled Taqman® Gene Expression Assays, GAPDH and 
18s were used to normalize mRNA (Applied Biosystems). 
58 IVDs were used for this component of the study 
(Supplementary Table 1).
chromatin immunoprecipitation
Human NP cells in 10-cm plates were treated 
with or without 2 mM DMOG for 24 h in normoxia or 
placed in hypoxia for 24 h. ChIP assay was performed 
using ChIP-IT® High Sensitivity kit (Active Motif, CA) 
following manufacturers recommendations and as reported 
previously [34]. DNA complexes were immunoprecipitated 
using HIF-1α antibody (Abcam) overnight at 4°C followed 
by binding to protein G-agarose beads. Cross-links were 
reversed by treatment with proteinase K and heat, and 
DNA was puriied using DNA puriication elution buffer. 
Real-time PCR analysis was performed using ChIP-IT® 
qPCR analysis kit (Active Motif). Negative control and 
standard curve primers used were provided with kit. 
Oncotarget11956www.impactjournals.com/oncotarget
Ct values for samples were recorded and the data were 
normalized based on primer eficiency, input DNA Ct 
values, amount of chromatin, and resuspension volume, 
based on manufacturer’s recommendations.
Western blotting
Cells were placed on ice following treatment and 
washed with ice-cold HBSS. All buffers included 1X 
protease inhibitor cocktail (Roche), NaF (5 mM) and 
Na3VO4 (200 μM). Total cell proteins were resolved 
on 8-12% SDS-polyacrylamide gels and transferred by 
electroblotting to PVDF membranes (Bio-Rad, CA). 
Membranes were blocked with 5% non-fat dry milk 
in TBST (50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% 
tween 20) and incubated overnight at 4°C in blocking 
buffer with the AQP1 (1:1500) (Millipore), AQP5 
(1:1000) (Millipore), or anti-β-tubulin antibody (1:2000, 
DSHB). Immunolabeling was detected with ECL reagent 
(Amersham). Blot intensity was determined using 
densitometric analysis (ImageQuant).
Immunoluorescence microscopy
Cells were plated in 96-well plates (4 × 103/well) 
then cultured in normoxia or hypoxia. After incubation, 
cells were ixed with 4% paraformaldehyde, permeabilized 
with 0.2% triton-X 100 in PBS for 10 min, blocked with 
PBS containing 5% FBS, and incubated with antibodies 
against AQP1, AQP5 (1:100, Millipore), or N-Cadherin 
(1:800 BD Transduction Laboratories) at 4°C overnight. 
For negative control, isotype IgG under similar conditions 
was used. After washing, the cells were incubated 
with Alexa luor-488 conjugated anti-rabbit or Alexa-
luor-594 conjugated anti-mouse secondary antibody 
(1:50, Invitrogen) and following washing imaged using a 
luorescence microscope (Nikon, Japan). 
transfections and dual luciferase assay
Cells were transferred to 48-well plates (2 × 104 
cells/well) one day pre-transfection. To measure hypoxic 
effect, cells were transfected with 250 ng of AQP reporters 
with 250 ng pRL-TK plasmid and cultured in normoxia 
or hypoxia for 24 h. For silencing, siHIF-1α (200 ng) or 
control siRNA (200 ng) was co-transfected with AQP 
reporter and pRLTK. In all experiments plasmids were 
premixed with the transfection reagent, LipofectAMINE 
2000 (Invitrogen). The next day, cells were harvested and 
Dual-Luciferase™ reporter assay system (Promega) was 
used for measurements of irely and Renilla luciferase 
activities using a luminometer (TD-20/20, Turner Designs, 
CA). 
lentiviral production and transduction
HEK 293T cells seeded in 10-cm plates (1.3 x 106 
cells/plate) were transfected with 9 µg of pLKO.1-Sh-Ctr 
(LV-Ctl) or LV-shHIF-1α plasmids along with 6 µg of 
psPAX2 and 3 µg of pMD2.G [35]. After 16 h, transfection 
media was removed and replaced with DMEM with 5% 
heat-inactivated FBS. Lentiviral particles were harvested 
at 48 and 60 h post-transfection. NP cells in 10-cm 
plates were transduced with 8 ml of conditioned media 
containing viral particles and 6 µg/ml of polybrene. After 
24 h, conditioned media was removed and replaced with 
DMEM, 5% FBS and cells harvested for analysis 5 days 
after transduction.
statistical analysis
All measurements were performed in triplicate. 
Results are presented as the mean ± S.E. Differences 
between groups were assessed by ANOVA and Student’s 
T-test. P-values < 0.05 were considered statistically 
signiicant. Human expression data was non-parametric, 
thus Kruskal-Wallis test with post-hoc analysis by 
Conover-Inman test was used to determine signiicance 
between 2-∆CT values and percentage immunopositivity 
between groups. Spearman’s rank correlation was used 
to determine correlations between gene and protein 
expression for different targets.
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